By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) – Artificial intelligence has sped up early-stage drug development work at some of the world's largest
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)